BloodSTAR (Blood System for Tracking Authorisations and Reviews) is a new ICT system currently under development by the National Blood Authority. The system will standardise and manage access to the supply of immunoglobulin products for the treatment of conditions identified in the Criteria for the clinical use of intravenous immunoglobulin in Australiafunded by all governments through the national blood arrangements.

Online version of the Criteria

An adaptation of the second edition of the Criteria has been included in BloodSTAR and is applicable for all states and territories except NSW from 2016. The Criteria as they appear in BloodSTAR (version 2.1) can be viewed here.

The inclusion of new ‘evidence items’ fields within the Criteria version 2.1 in BloodSTAR does not change the basis for approval of authorisation of Ig product. 

What is BloodSTAR?

Moving or Travelling Patient Process during BloodSTAR Transition

For guidance when patients receiving immunoglobulin products travel or move between States and/or Territories where BloodSTAR may or may not have been implemented, please refer to the below document.

BloodSTAR and BloodNet Downtime Process

Details in the documents below on the steps to undertake if BloodSTAR or BloodNet are unavailable

    Further Information

    Definitions (34.66 KB) Definitions (124.98 KB)

    To discuss BloodSTAR further, please don’t hesitate to contact the Blood Operations Centre on 13 000 BLOOD (13 000 25663) or support [at] .